- Release Date: 13/09/23 09:42
- Summary: Phase 3 Common Cold Trial Results
- Price Sensitive: Yes
- Download Document 185.34KB
- Forums
- ASX - By Stock
- FRE
- Ann: Phase 3 Common Cold Trial Results
FRE
firebrick pharma limited
Add to My Watchlist
11.4%
!
6.2¢

Ann: Phase 3 Common Cold Trial Results
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.2¢ |
Change
-0.008(11.4%) |
Mkt cap ! $13.92M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.2¢ | $1.203K | 18.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23500 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 1716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23500 | 0.062 |
1 | 30000 | 0.061 |
2 | 142353 | 0.060 |
1 | 19888 | 0.059 |
1 | 9925 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 1716 | 1 |
0.079 | 114833 | 1 |
0.080 | 47101 | 2 |
0.088 | 5758 | 2 |
0.089 | 15000 | 1 |
Last trade - 10.42am 26/06/2025 (20 minute delay) ? |
Featured News
FRE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online